Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy.
D033942:Adaptor Proteins, Vesicular Transport / Q000096:biosynthesis / Q000235:genetics; D000328:Adult; D000368:Aged; D000465:Algorithms; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000401:mortality / Q000601:surgery; D002277:Carcinoma / Q000188:drug therapy / Q000235:genetics* / Q000401:mortality / Q000601:surgery; D054370:Chemokine CXCL9 / Q000096:biosynthesis / Q000235:genetics; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D018572:Disease-Free Survival; D005240:Feasibility Studies; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D005500:Follow-Up Studies; D051960:GTP-Binding Protein alpha Subunit, Gi2 / Q000096:biosynthesis / Q000235:genetics; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006657:Histones / Q000096:biosynthesis / Q000235:genetics; D006801:Humans; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase / Q000096:biosynthesis / Q000235:genetics; D008408:Mastectomy; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000096:biosynthesis / Q000235:genetics*; D020411:Oligonucleotide Array Sequence Analysis; D012333:RNA, Messenger / Q000235:genetics; D012334:RNA, Neoplasm / Q000235:genetics; D012008:Recurrence
D033942:Adaptor Proteins, Vesicular Transport; C080810:CXCL9 protein, human; D054370:Chemokine CXCL9; C468783:H2AX protein, human; D006657:Histones; C509776:ITSN2 protein, human; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase; D009363:Neoplasm Proteins; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D003520:Cyclophosphamide; C498015:GNAI2 protein, human; D051960:GTP-Binding Protein alpha Subunit, Gi2; D005472:Fluorouracil; D008727:Methotrexate